이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Jinhe Biotechnology 관리

관리 기준 확인 3/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Changxian Xie

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	16.7yrs
CEO 소유권	0.4%
경영진 평균 재임 기간	9.9yrs
이사회 평균 재임 기간	9.7yrs

최근 관리 업데이트

Recent updates

Jinhe Biotechnology (SZSE:002688) Is Due To Pay A Dividend Of CN¥0.10

May 27

Subdued Growth No Barrier To Jinhe Biotechnology CO., LTD. (SZSE:002688) With Shares Advancing 26%

May 13

Jinhe Biotechnology CO., LTD. (SZSE:002688) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

May 13

CEO

Changxian Xie (62 yo)

16.7yrs

테뉴어

CN¥566,100

보상

Mr. Changxian Xie serves as General Manager at Jinhe Biotechnology CO., LTD. and serves as its Director since November 27, 2007.

리더십 팀

이름	위치	테뉴어	보상	소유권
Changxian Xie	GM & Director	no data	CN¥566.10k	0.43% CN¥ 12.0m
You Shan Niu	Financial Director	9.9yrs	CN¥297.90k	0.039% CN¥ 1.1m
Zhi Jun Wang	Deputy GM & Director	10.3yrs	CN¥680.40k	데이터 없음
Manman Lu	Board Secretary & Director	3.3yrs	CN¥292.10k	1.0% CN¥ 27.6m
Zhi Sheng Wang	Deputy General Manager	10.3yrs	CN¥274.80k	데이터 없음
Ying Chun Liu	Deputy General Manager	13.6yrs	CN¥298.50k	0.083% CN¥ 2.3m
Yueqing Wang	Deputy GM & Non-Independent Director	1.2yrs	데이터 없음	0.039% CN¥ 1.1m
Yingzhen Guan	Deputy General Manager	7.5yrs	데이터 없음	0.039% CN¥ 1.1m

9.9yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 관리: 002688 의 관리팀은 노련하고 경험 (평균 재직 기간 10 년)입니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Changxian Xie	GM & Director	16.7yrs	CN¥566.10k	0.43% CN¥ 12.0m
Zhi Jun Wang	Deputy GM & Director	10.3yrs	CN¥680.40k	데이터 없음
Manman Lu	Board Secretary & Director	1.2yrs	CN¥292.10k	1.0% CN¥ 27.6m
Yueqing Wang	Deputy GM & Non-Independent Director	1.2yrs	데이터 없음	0.039% CN¥ 1.1m
Dongxiao Wang	Chairman	16.7yrs	CN¥844.80k	31.67% CN¥ 877.6m
Fu Zhong Li	Vice Chairman of Board of Directors	16.7yrs	CN¥598.60k	0.73% CN¥ 20.2m
Qian Sui Zhang	Chairman of the Supervisory Board	9.2yrs	데이터 없음	데이터 없음
Jian Xiong Yao	Shareholder Representative Supervisor	10.3yrs	데이터 없음	데이터 없음
Liu Ji Zheng	Employee Representative Supervisor	10.3yrs	데이터 없음	데이터 없음
Minpu Yao	Independent Director	4.2yrs	CN¥82.80k	데이터 없음
Xiaoyan Xie	Independent Director	4.2yrs	CN¥82.80k	데이터 없음
Wenbing Lu	Independent Director	4.2yrs	CN¥82.80k	데이터 없음

9.7yrs

평균 재임 기간

56.5yo

평균 연령

경험이 풍부한 이사회: 002688 의 이사회는 경험(평균 재직 기간 9.6 년)으로 간주됩니다.

Jinhe Biotechnology 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Jinhe Biotechnology CO., LTD., Annual General Meeting, May 20, 2024

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Jinhe Biotechnology CO., LTD., Annual General Meeting, May 12, 2022

Recent updates

Jinhe Biotechnology CO., LTD. to Report First Half, 2024 Results on Aug 29, 2024

Investor sentiment deteriorates as stock falls 16%

Jinhe Biotechnology (SZSE:002688) Is Due To Pay A Dividend Of CN¥0.10

Dividend of CN¥0.10 announced

Jinhe Biotechnology CO., LTD. Announces Final Cash Dividend on A Shares for the Year 2023, Payable on 31 May 2024

Subdued Growth No Barrier To Jinhe Biotechnology CO., LTD. (SZSE:002688) With Shares Advancing 26%

Jinhe Biotechnology CO., LTD. (SZSE:002688) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected

Jinhe Biotechnology CO., LTD., Annual General Meeting, May 20, 2024

Jinhe Biotechnology CO., LTD. to Report Q1, 2024 Results on Apr 29, 2024

Less than half of directors are independent

Jinhe Biotechnology CO., LTD. (SZSE:002688) announces an Equity Buyback for CNY 100 million worth of its shares.

Jinhe Biotechnology CO., LTD. to Report Fiscal Year 2023 Results on Apr 29, 2024

Jinhe Biotechnology CO., LTD. Approves Change of Accounting Policies

Third quarter 2023 earnings released: EPS: CN¥0.018 (vs CN¥0.02 in 3Q 2022)

Less than half of directors are independent

Jinhe Biotechnology CO., LTD. to Report Q3, 2023 Results on Oct 30, 2023

Second quarter 2023 earnings released: EPS: CN¥0.067 (vs CN¥0.072 in 2Q 2022)

Jinhe Biotechnology CO., LTD. to Report First Half, 2023 Results on Aug 23, 2023

Jinhe Biotechnology Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 05 June 2023

Jinhe Biotechnology CO., LTD. announced that it expects to receive CAD 124.8 million in funding from Jinhe Youben Biological Products Co., Ltd.

First quarter 2023 earnings released: EPS: CN¥0.047 (vs CN¥0.04 in 1Q 2022)

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.02 (vs CN¥0.012 in 3Q 2021)

Second quarter 2022 earnings released: EPS: CN¥0.072 (vs CN¥0.049 in 2Q 2021)

Jinhe Biotechnology CO., LTD. (SZSE:002688) commences an Equity Buyback Plan for CNY 200 million worth of its shares, under the authorization approved on May 12, 2022.

Less than half of directors are independent

Jinhe Biotechnology CO., LTD., Annual General Meeting, May 12, 2022

Third quarter 2021 earnings released: EPS CN¥0.012 (vs CN¥0.011 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.049 (vs CN¥0.061 in 2Q 2020)

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS CN¥0.13 (vs CN¥0.09 in 1Q 2020)

Full year 2020 earnings released: EPS CN¥0.18 (vs CN¥0.29 in FY 2019)

New 90-day high: CN¥6.48

Jinhe Biotechnology CO., LTD. to Report Fiscal Year 2020 Results on Mar 31, 2021

Investor sentiment improved over the past week

New 90-day low: CN¥5.27

New 90-day low: CN¥5.71

Third quarter earnings released

New 90-day low: CN¥6.70

Jinhe Biotechnology CO., LTD. to Report Q3, 2020 Results on Oct 20, 2020

New 90-day low: CN¥6.84

Earnings released

Jinhe Biotechnology CO., LTD. to Report First Half, 2020 Results on Aug 24, 2020

CEO

테뉴어

보상

리더십 팀

평균 재임 기간

평균 연령

이사회 구성원

평균 재임 기간

평균 연령